CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events (Q40071909)

17 September 2017

title

CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events (English)

1 reference

17 September 2017

main subject

acute coronary syndrome

1 reference

12

J Wouter Jukema

1 reference

17 September 2017

11

Martin J Schalij

1 reference

17 September 2017

10

Douwe E Atsma

1 reference

17 September 2017

6

Bas L van der Hoeven

1 reference

17 September 2017

1

Saskia C A de Jager

1 reference

17 September 2017

13

Erik A L Biessen

1 reference

17 September 2017

author name string

Adriaan O Kraaijeveld

2

1 reference

17 September 2017

Robert W Grauss

3

1 reference

17 September 2017

Wilco de Jager

4

1 reference

17 September 2017

Su-San Liem

5

1 reference

17 September 2017

Berent J Prakken

7

1 reference

17 September 2017

Hein Putter

8

1 reference

17 September 2017

Theo J C van Berkel

9

1 reference

17 September 2017

publication date

21 June 2008

1 reference

Journal of Molecular and Cellular Cardiology

17 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

17 September 2017

volume

45

1 reference

17 September 2017

issue

3

1 reference

17 September 2017

page(s)

446-452

1 reference

Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Myocardial apoptosis associated with the expression of proinflammatory cytokines during the course of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Serum MCP-1 and VEGF levels are not affected by inhibition of the renin-angiotensin system in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

The role of the chemokines in myocardial ischemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

MISSION!: optimization of acute and chronic care for patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Relationship between CRP and clinical course of unstable angina depends on assay method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Changes in serum interleukin-8 and interleukin-12 levels in patients with ischemic heart disease in a Chinese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Serum profiles of C-C chemokines in acute myocardial infarction: possible implication in postinfarction left ventricular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Molecular dynamics of the compensatory response to myocardial infarct.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Elevated plasma interleukin-6 levels in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Platelet-derived CD40L: the switch-hitting player of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Non-lipid effects of statin on hypercholesterolemic patients established to have coronary artery disease who remained hypercholesterolemic while eating a step-II diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Simvastatin exerts its anti-inflammatory effect in hypercholesterolaemic patients by decreasing the serum levels of monocyte chemoattractant protein-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Pravastatin suppresses the interleukin-8 production induced by thrombin in human aortic endothelial cells cultured with high glucose by inhibiting the p44/42 mitogen activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

Inhibitory effect of pitavastatin (NK-104) on the C-reactive-protein-induced interleukin-8 production in human aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.003

10.1016/J.YJMCC.2008.06.003

7 January 2021

Identifiers

DOI

1 reference

17 September 2017

1 reference